Raymond James Financial Services Advisors Inc. raised its holdings in Balchem Co. (NASDAQ:BCPC – Get Rating) by 574.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 13,122 shares of the basic materials company’s stock after buying an additional 11,176 shares during the period. Raymond James Financial Services Advisors Inc.’s holdings in Balchem were worth $1,595,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also recently made changes to their positions in the business. Franklin Resources Inc. lifted its stake in shares of Balchem by 4.6% in the second quarter. Franklin Resources Inc. now owns 2,125 shares of the basic materials company’s stock valued at $276,000 after buying an additional 93 shares in the last quarter. Legacy Wealth Asset Management LLC lifted its stake in shares of Balchem by 3.0% in the second quarter. Legacy Wealth Asset Management LLC now owns 3,262 shares of the basic materials company’s stock valued at $423,000 after buying an additional 94 shares in the last quarter. Exchange Traded Concepts LLC lifted its stake in shares of Balchem by 2.6% in the second quarter. Exchange Traded Concepts LLC now owns 4,669 shares of the basic materials company’s stock valued at $606,000 after buying an additional 120 shares in the last quarter. Cardinal Capital Management lifted its stake in shares of Balchem by 0.7% in the second quarter. Cardinal Capital Management now owns 18,485 shares of the basic materials company’s stock valued at $2,398,000 after buying an additional 127 shares in the last quarter. Finally, Great West Life Assurance Co. Can raised its holdings in shares of Balchem by 0.5% in the first quarter. Great West Life Assurance Co. Can now owns 28,110 shares of the basic materials company’s stock valued at $3,943,000 after purchasing an additional 132 shares during the last quarter. 89.29% of the stock is owned by institutional investors.
Balchem Stock Performance
NASDAQ BCPC opened at $126.45 on Thursday. Balchem Co. has a 52-week low of $110.15 and a 52-week high of $152.81. The company has a 50-day simple moving average of $130.74 and a 200 day simple moving average of $130.55. The company has a debt-to-equity ratio of 0.54, a quick ratio of 1.61 and a current ratio of 2.59. The company has a market capitalization of $4.06 billion, a PE ratio of 37.75 and a beta of 0.67.
Balchem Increases Dividend
The business also recently disclosed an annual dividend, which will be paid on Friday, January 20th. Investors of record on Tuesday, December 27th will be issued a dividend of $0.71 per share. This represents a yield of 0.53%. The ex-dividend date of this dividend is Friday, December 23rd. This is an increase from Balchem’s previous annual dividend of $0.64. Balchem’s dividend payout ratio (DPR) is 21.19%.
Analyst Upgrades and Downgrades
Several analysts have recently commented on BCPC shares. StockNews.com started coverage on shares of Balchem in a report on Wednesday, October 12th. They issued a “hold” rating for the company. HC Wainwright lowered their target price on shares of Balchem from $164.00 to $152.00 and set a “buy” rating for the company in a report on Monday, November 7th.
Balchem Company Profile
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
- Get a free copy of the StockNews.com research report on Balchem (BCPC)
- Procter & Gamble Earnings: A Gamble Worth Taking
- Stocks Slide, Economic Report Paints Gloomy Picture For Economy
- What does Nu Holdings Stock Have To Do With Warren Buffett?
- J.B. Hunt Gets A Flat, Logistic Companies Come Into Focus
- Is Intel Stock On The Verge Of Breaking Out?
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.